BR112012000281A2 - proteína quimérica. - Google Patents
proteína quimérica.Info
- Publication number
- BR112012000281A2 BR112012000281A2 BR112012000281A BR112012000281A BR112012000281A2 BR 112012000281 A2 BR112012000281 A2 BR 112012000281A2 BR 112012000281 A BR112012000281 A BR 112012000281A BR 112012000281 A BR112012000281 A BR 112012000281A BR 112012000281 A2 BR112012000281 A2 BR 112012000281A2
- Authority
- BR
- Brazil
- Prior art keywords
- chimeric protein
- chimeric
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0911794.6A GB0911794D0 (en) | 2009-07-07 | 2009-07-07 | Chimaeric protein |
| PCT/GB2010/001293 WO2011004146A1 (en) | 2009-07-07 | 2010-07-05 | Chimaeric protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112012000281A2 true BR112012000281A2 (pt) | 2016-08-09 |
| BR112012000281A8 BR112012000281A8 (pt) | 2016-09-06 |
Family
ID=41022290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012000281A BR112012000281A8 (pt) | 2009-07-07 | 2010-07-05 | Proteína quimérica |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8828407B2 (pt) |
| EP (1) | EP2451827B1 (pt) |
| CN (1) | CN102574897B (pt) |
| BR (1) | BR112012000281A8 (pt) |
| ES (1) | ES2589057T3 (pt) |
| GB (1) | GB0911794D0 (pt) |
| HU (1) | HUE029073T2 (pt) |
| PL (1) | PL2451827T3 (pt) |
| WO (1) | WO2011004146A1 (pt) |
| ZA (1) | ZA201200200B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103060325B (zh) * | 2013-01-14 | 2015-01-07 | 韩健宝 | 抗猪流行性腹泻病毒pedv的反义核酸及肽核酸pna |
| CN104072592B (zh) * | 2013-03-26 | 2016-12-28 | 复旦大学 | 对新型冠状病毒HCoV-EMC 2012感染具有抑制作用的多肽及其应用 |
| GB201308057D0 (en) | 2013-05-03 | 2013-06-12 | Pirbright Inst The | Protein |
| GB201310031D0 (en) * | 2013-06-05 | 2013-07-17 | Pirbright Inst The | Cell |
| CN103394097A (zh) * | 2013-06-09 | 2013-11-20 | 东北农业大学 | 猪传染性胃肠炎和流行性腹泻两联疫苗的引物及制备方法 |
| GB201413020D0 (en) | 2014-07-23 | 2014-09-03 | Pribright The Inst | Coronavirus |
| CN104262488B (zh) * | 2014-09-24 | 2017-07-28 | 普莱柯生物工程股份有限公司 | 一种融合蛋白及其疫苗组合物的制备与应用 |
| GB201601498D0 (en) | 2016-01-27 | 2016-03-09 | Pirbright Inst The | Coronavirus |
| AR116876A1 (es) * | 2018-10-31 | 2021-06-23 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna de ibv 4/91 con proteína espicular heteróloga |
| MY206043A (en) * | 2018-10-31 | 2024-11-26 | Boehringer Ingelheim Vetmedica Gmbh | H52 ibv vaccine with heterologous spike protein |
| CN109943536B (zh) * | 2019-03-26 | 2021-09-14 | 昆明理工大学 | 一种戊型肝炎病毒的培养方法及其灭活疫苗的制备方法 |
| EP3966318A1 (en) * | 2019-05-10 | 2022-03-16 | Boehringer Ingelheim Vetmedica GmbH | Attenuated ibv with extended cell culture and tissue tropism |
| EP3966228A1 (en) | 2019-05-10 | 2022-03-16 | Boehringer Ingelheim Vetmedica GmbH | Modified s2 subunit of the coronavirus spike protein |
| US11512115B2 (en) * | 2019-05-10 | 2022-11-29 | Boehringer Ingelheim Vetmedica Gmbh | Modified S1 subunit of the coronavirus spike protein |
| CN110894217B (zh) * | 2019-12-16 | 2021-07-13 | 中国农业大学 | 一种牛冠状病毒嵌合抗原以及检测牛冠状病毒抗体的胶体金免疫层析试纸卡 |
| US10975126B1 (en) | 2020-04-23 | 2021-04-13 | King Faisal University | MERS-CoV inhibitor peptides |
| CN111607003B (zh) * | 2020-05-21 | 2022-08-23 | 上海百英生物科技有限公司 | 一种SARS-CoV-2 N/S1(RBD)重组蛋白及制备方法和应用 |
| KR20220002156A (ko) * | 2020-06-30 | 2022-01-06 | 포항공과대학교 산학협력단 | 코로나-19 바이러스의 스파이크 단백질의 에스터가수분해효소 활성을 이용한 코로나 바이러스 감염증 치료제 스크리닝 키트 및 상기 키트를 이용하여 스크리닝된 물질을 포함하는 코로나 바이러스 감염증의 예방 또는 치료용 약학 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078203A2 (en) | 2003-03-03 | 2004-09-16 | Akzo Nobel N.V. | Infectious bronchitis virus with an altered spike gene |
| CN100374460C (zh) * | 2004-07-05 | 2008-03-12 | 华中农业大学 | 含有与鸡传染性支气管炎病毒特异性结合短肽的噬菌体及应用 |
| CN1763085A (zh) * | 2005-11-02 | 2006-04-26 | 浙江大学 | 鸡传染性支气管炎病毒s1重组蛋白抗原、制备方法及用途 |
| CN101240289A (zh) * | 2008-03-11 | 2008-08-13 | 四川大学 | 一种禽传染性支气管炎病毒S1基因与禽IL-2基因共表达DNA疫苗pIRES-S1/IL2 |
-
2009
- 2009-07-07 GB GBGB0911794.6A patent/GB0911794D0/en not_active Ceased
-
2010
- 2010-07-05 ES ES10734527.4T patent/ES2589057T3/es active Active
- 2010-07-05 US US13/382,119 patent/US8828407B2/en active Active
- 2010-07-05 WO PCT/GB2010/001293 patent/WO2011004146A1/en not_active Ceased
- 2010-07-05 PL PL10734527.4T patent/PL2451827T3/pl unknown
- 2010-07-05 EP EP10734527.4A patent/EP2451827B1/en active Active
- 2010-07-05 CN CN201080039682.7A patent/CN102574897B/zh active Active
- 2010-07-05 HU HUE10734527A patent/HUE029073T2/en unknown
- 2010-07-05 BR BR112012000281A patent/BR112012000281A8/pt not_active IP Right Cessation
-
2012
- 2012-01-10 ZA ZA2012/00200A patent/ZA201200200B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012000281A8 (pt) | 2016-09-06 |
| HUE029073T2 (en) | 2017-02-28 |
| GB0911794D0 (en) | 2009-08-19 |
| PL2451827T3 (pl) | 2016-12-30 |
| US20120177675A1 (en) | 2012-07-12 |
| EP2451827A1 (en) | 2012-05-16 |
| ES2589057T3 (es) | 2016-11-08 |
| CN102574897A (zh) | 2012-07-11 |
| ZA201200200B (en) | 2013-03-27 |
| US8828407B2 (en) | 2014-09-09 |
| WO2011004146A1 (en) | 2011-01-13 |
| CN102574897B (zh) | 2015-03-11 |
| EP2451827B1 (en) | 2016-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012000281A2 (pt) | proteína quimérica. | |
| BRPI1009415A2 (pt) | escova de dentes. | |
| EP2406399A4 (en) | MIRAC PROTEINS | |
| BR112012002226A2 (pt) | anticorpos muc1. | |
| BRPI1010301A2 (pt) | composição. | |
| PT2406284T (pt) | Anticorpos anti-bcma | |
| BRPI1009789A2 (pt) | desacoplador. | |
| EP2472185A4 (en) | HEATING DEVICE | |
| BRPI1009811A2 (pt) | transmissão. | |
| FR2947376B1 (fr) | Sectionneur. | |
| IT1396487B1 (it) | Convogliatore. | |
| DK2442870T3 (da) | Pyrazinooxazepin-derivater. | |
| BRPI1016192A2 (pt) | derivados de soxazol. | |
| BRPI1011794A2 (pt) | compartimento. | |
| BRPI1008952A2 (pt) | Composição herbicida. | |
| FR2946497B1 (fr) | Elagueuse autonome | |
| FR2942385B1 (fr) | Grille-pain. | |
| IT1392420B1 (it) | Lavastoviglie. | |
| BRPI1008675A2 (pt) | grânulos. | |
| BR112012014495A2 (pt) | cosmético de autonivelamento. | |
| IT1396642B1 (it) | Statore. | |
| FR2943510B1 (fr) | Ombrelle. | |
| BRPI1009515A2 (pt) | Complexos de proteínas/glicosinolatos eletrostáticos. | |
| BRPI1007268A2 (pt) | Combinações pesticidas. | |
| IT1401345B1 (it) | Bomboletta. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: THE PIRBRIGHT INSTITUTE (GB) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 15A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2840 DE 10/06/2025. |